Patents by Inventor Yutaka Sashida
Yutaka Sashida has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9017739Abstract: The present invention provides a method for suppressing and relieving itching and inflammation, by administering to a host in need of such treatment an effective amount of the pharmaceutical composition containing highly lipophilic polyalkoxyflavonoid. The pharmaceutical composition and functional food of the present invention for suppressing and relieving itching and inflammation contain highly lipophilic polyalkoxyflavonoid extracted from squeezed juice of a whole portion of a citrus fruit (inclusive of pericarp thereof). Furthermore, the functional food of the present invention contains it.Type: GrantFiled: October 18, 2014Date of Patent: April 28, 2015Assignees: Kands R&D Corporation, Erina Co., Inc.Inventors: Kazue Taguchi, Shigeru Taguchi, Yutaka Sashida
-
Publication number: 20150037440Abstract: The present invention provides a method for suppressing and relieving itching and inflammation, by administering to a host in need of such treatment an effective amount of the pharmaceutical composition containing highly lipophilic polyalkoxyflavonoid. The pharmaceutical composition and functional food of the present invention for suppressing and relieving itching and inflammation contain highly lipophilic polyalkoxyflavonoid extracted from squeezed juice of a whole portion of a citrus fruit (inclusive of pericarp thereof). Furthermore, the functional food of the present invention contains it.Type: ApplicationFiled: October 18, 2014Publication date: February 5, 2015Applicants: ERINA CO., INC., KANDS R&D CORPORATIONInventors: KAZUE TAGUCHI, SHIGERU TAGUCHI, YUTAKA SASHIDA
-
Patent number: 8889198Abstract: The present invention provides a method for suppressing and relieving itching and inflammation, by administering to a host in need of such treatment an effective amount of the pharmaceutical composition containing highly lipophilic polyalkoxyflavonoid. The pharmaceutical composition and functional food of the present invention for suppressing and relieving itching and inflammation contain highly lipophilic polyalkoxyflavonoid extracted from squeezed juice of a whole portion of a citrus fruit (inclusive of pericarp thereof). Furthermore, the functional food of the present invention contains it.Type: GrantFiled: February 10, 2012Date of Patent: November 18, 2014Assignee: Kands R&D Corp.Inventors: Kazue Taguchi, Shigeru Taguchi, Yutaka Sashida
-
Publication number: 20120141615Abstract: The present invention provides a method for suppressing and relieving itching and inflammation, by administering to a host in need of such treatment an effective amount of the pharmaceutical composition containing highly lipophilic polyalkoxyflavonoid. The pharmaceutical composition and functional food of the present invention for suppressing and relieving itching and inflammation contain highly lipophilic polyalkoxyflavonoid extracted from squeezed juice of a whole portion of a citrus fruit (inclusive of pericarp thereof). Furthermore, the functional food of the present invention contains it.Type: ApplicationFiled: February 10, 2012Publication date: June 7, 2012Applicants: ERINA CO., INC., KANDS R&D CORPORATIONInventors: Kazue TAGUCHI, Shigeru TAGUCHI, Yutaka SASHIDA
-
Patent number: 7888388Abstract: The present invention easily and efficiently provides a peroxisome proliferator-activated receptor ligand, and a composition for amelioration of insulin resistance or for prevention and/or amelioration of the insulin resistance syndrome containing the same, as an active ingredient. The present invention relates to a peroxisome proliferator-activated receptor ligand which comprises a prenylflavonoid, a chalcone derivative exclusive of prenylflavonoids, a flavonol derivative exclusive of prenylflavonoids, and a salt, a glycoside and/or an esterified substance thereof acceptable as a pharmaceutical preparation or a food or a beverage; a composition containing the above ligand; a plant-derived extract containing the above ligand; and a process for producing the above extract.Type: GrantFiled: September 18, 2008Date of Patent: February 15, 2011Assignee: Kaneka CorporationInventors: Tatsumasa Mae, Misuzu Tsukagawa, Mikio Kitahara, Kaku Nakagawa, Shiro Kitamura, Yasuyoshi Ueda, Minpei Kuroda, Yoshihiro Mimaki, Yutaka Sashida
-
Publication number: 20090304828Abstract: It is intended to provide a drug and a functional food by which any itching such as common itching and intractable itching can be safely controlled and relieved and, furthermore, inflammation can be controlled and relieved. A medicine capable of controlling and relieving itching and inflammation which contains a highly lipophilic polyalkoxyflavonoid extracted from a press juice of a whole citrus fruit (a fruit having its peel), and a function food containing this medicine.Type: ApplicationFiled: February 19, 2007Publication date: December 10, 2009Applicant: KANDS R&D CORPORATIONInventors: Kazue Taguchi, Shigeru Taguchi, Yutaka Sashida
-
Patent number: 7563913Abstract: There are provided novel compounds that have been extracted and isolated from a plant belonging to the family Compositae. Compounds represented by general formula (I): wherein R1 represents hydroxyl and R2 represents methoxy.Type: GrantFiled: November 25, 2003Date of Patent: July 21, 2009Assignee: Hiro International Co., Ltd.Inventors: Yutaka Sashida, Yoshihiro Mimaki, Minpei Kuroda, Ryosuke Kobayashi, Hiroaki Kando, Kosuke Nosaka, Hiroyasu Ishii, Takao Yamori
-
Patent number: 7524975Abstract: The present invention easily and efficiently provides a peroxisome proliferator-activated receptor ligand, and a composition for amelioration of insulin resistance or for prevention and/or amelioration of the insulin resistance syndrome containing the same, as an active ingredient. The present invention relates to a peroxisome proliferator-activated receptor ligand which comprises a prenylflavonoid, a chalcone derivative exclusive of prenylflavonoids, a flavonol derivative exclusive of prenylflavonoids, and a salt, a glycoside and/or an esterified substance thereof acceptable as a pharmaceutical preparation or a food or a beverage; a composition containing the above ligand; a plant-derived extract containing the above ligand; and a process for producing the above extract.Type: GrantFiled: October 11, 2002Date of Patent: April 28, 2009Assignee: Kaneka CorporationInventors: Tatsumasa Mae, Misuzu Tsukagawa, Mikio Kitahara, Kaku Nakagawa, Shiro Kitamura, Yasuyoshi Ueda, Minpei Kuroda, Yoshihiro Mimaki, Yutaka Sashida
-
Publication number: 20090036519Abstract: The present invention easily and efficiently provides a peroxisome proliferator-activated receptor ligand, and a composition for amelioration of insulin resistance or for prevention and/or amelioration of the insulin resistance syndrome containing the same, as an active ingredient. The present invention relates to a peroxisome proliferator-activated receptor ligand which comprises a prenylflavonoid, a chalcone derivative exclusive of prenylflavonoids, a flavonol derivative exclusive of prenylflavonoids, and a salt, a glycoside and/or an esterified substance thereof acceptable as a pharmaceutical preparation or a food or a beverage; a composition containing the above ligand; a plant-derived extract containing the above ligand; and a process for producing the above extract.Type: ApplicationFiled: September 18, 2008Publication date: February 5, 2009Inventors: Tatsumasa MAE, Misuzu Tsukagawa, Mikio Kitahara, Kaku Nakagawa, Shiro Kitamura, Yasuyoshi Ueda, Minpei Kuroda, Yoshihiro Mimaki, Yutaka Sashida
-
Publication number: 20070129427Abstract: There are provided novel compounds that have been extracted and isolated from a plant belonging to the family Compositae. Compounds represented by general formula (I): wherein R1 represents hydroxyl and R2 represents methoxy.Type: ApplicationFiled: November 25, 2003Publication date: June 7, 2007Applicant: HIRO INTERNATIONAL CO., LTD.Inventors: Yutaka Sashida, Yoshihiro Mimaki, Minpei Kuroda, Ryosuke Kobayashi, Hiroaki Kando, Kosuke Nosaka, Hiroyasu Ishii, Takao Yamori
-
Patent number: 7090874Abstract: The object of the present invention is to provide PPAR? ligand derived from naturally occurring sources and a composition for preventing and/or improving Insulin Resistance Syndrome, diabetes mellitus, obesity or visceral fat obesity comprising the PPAR? ligand as an active agent. The present invention relates to a ligand for peroxisome proliferator-activated receptor which comprises curcumin or its derivatives. The composition according to the present invention, which comprises the PPAR? ligand as an active agent is useful for preventing and/or improving Insulin Resistance Syndrome, diabetes mellitus, obesity or visceral fat obesity.Type: GrantFiled: January 8, 2004Date of Patent: August 15, 2006Assignee: Kaneka CorporationInventors: Tatsumasa Mae, Misuzu Tsukagawa, Hideyuki Kishida, Mitsuaki Kitano, Mikio Kitahara, Kaku Nakagawa, Minpei Kuroda, Yoshihiro Mimaki, Yutaka Sashida
-
Publication number: 20050014819Abstract: The present invention easily and efficiently provides a peroxisome proliferator-activated receptor ligand, and a composition for amelioration of insulin resistance or for prevention and/or amelioration of the insulin resistance syndrome containing the same, as an active ingredient. The present invention relates to a peroxisome proliferator-activated receptor ligand which comprises a prenylflavonoid, a chalcone derivative exclusive of prenyl flavonoids, a flavonol derivative exclusive of prenylflavonoids, and a salt, a glycoside and/or an esterified substance thereof acceptable as a pharmaceutical preparation or a food or a beverage; a composition containing the above ligand; a plant-derived extract containing the above ligand; and a process for producing the above extract.Type: ApplicationFiled: October 11, 2002Publication date: January 20, 2005Inventors: Tatsumasa Mae, Misuzu Tsukagawa, Mikio Kitahara, Kaku Nakagawa, Shiro Kitamura, Yasuyoshi Ueda, Minpei Kuroda, Yoshihiro Mimaki, Yutaka Sashida
-
Publication number: 20040253329Abstract: The object of the present invention is to provide PPAR&ggr; ligand derived from naturally occurring sources and a composition for preventing and/or improving Insulin Resistance Syndrome, diabetes mellitus, obesity or visceral fat obesity comprising the PPAR&ggr; ligand as an active agent.Type: ApplicationFiled: January 8, 2004Publication date: December 16, 2004Inventors: Tatsumasa Mae, Misuzu Tsukagawa, Hideyuki Kishida, Mitsuaki Kitano, Mikio Kitahara, Kaku Nakagawa, Minpei Kuroda, Yoshihiro Mimaki, Yutaka Sashida
-
Publication number: 20030147979Abstract: The object of the present invention is to provide PPAR&ggr; ligand derived from naturally occurring sources and a composition for preventing and/or improving Insulin Resistance Syndrome, diabetes mellitus, obesity or visceral fat obesity comprising the PPAR&ggr; ligand as an active agent.Type: ApplicationFiled: October 23, 2002Publication date: August 7, 2003Inventors: Tatsumasa Mae, Misuzu Tsukagawa, Hideyuki Kishida, Mitsuaki Kitano, Mikio Kitahara, Kaku Nakagawa, Minpei Kuroda, Yoshihiro Mimaki, Yutaka Sashida